CEO Alan Shortall Talks On Unilife Corp (NASDAQ:UNIS) 4Q2014 Results

Boston, MA 09/11/2014 (wallstreetpr) – Alan Shortall, Chairman and the CEO of Unilife Corp (NASDAQ:UNIS) discussed the fourth quarter results on a conference call held on Wednesday. Shortall started the talks on the positive note as he said that the management is delighted with the trajectory of the business. Unilife is well positioned to deliver higher revenue growth in the coming years. The commercial sales will form an important part of the revenue in the coming time. Unilife has started the commercial shipments of its products to consumers.

The performance

Shortall said that fiscal year 2014 was a year of accelerated growth in terms of customers, revenues, production and supply agreements. Unilife Corp (NASDAQ:UNIS) signed various agreements with customers including Sanofi SA (ADR) (NYSE:SNY), MedImmune, Inc., Novartis AG (ADR) (NYSE:NVS) and others. The financial performance was impressive as full year revenue came at $14.7 million, up 400% compared to fiscal year 2013. The full year revenue was at the high end of the range of provided guidance. The deferred revenue came higher at $13.3 million. The cash receipts from customers amounted to $23.7 million. up $22.5 million from last year. There was a rise in R&D investment but still it cannot affect the net operating cash flow which improved by 20% as compared to fiscal 2013.

Reasons for growth

The strong fiscal year can be attributed to two reasons. First, Unilife signed new agreements and successfully executed existing agreements in the year. Second, the differentiated business model of Unilife is accepted by various biotech and pharmaceutical companies. These companies understand the significance of long-term commercial partnerships with Unilife. In last 18 months, Unilife has been successful in converting the commercial pipeline into long-term strategic relationships. Also, the focus in fiscal year was on R&D activities. Unilife Corp (NASDAQ:UNIS) invested around $16 million in facilities, capital expenditures and R&D. The investment was made in order to meet the increased commercial needs of customers.

Please make sure to read and completely understand our disclaimer at https://www.wallstreetpr.com/disclaimer. We may be compensated for posting this content on our website by EDM Media LLC. For questions, comments or suggestions please contact ir@edm.media.

Published by Van Bettauer

Van Bettauer is a financial aficionado from Vancouver, British Columbia. He currently studies at UBC, pursuing a Bachelors of Science degree. Van has been freelance writing for many years, specializing in copywriting, report writing and article writing. The combination of his scientific studies and writing experience brings a new and fresh perspective to the financial world. Visit Bettauer's Google+ page at the following address: https://plus.google.com/100770875710593766367/posts

Recent Stories

SignUp Now For Our Featured Newsletter